Dr. HASSAN HAMDAN ALHASSAN

Assistant Professor within approximately 2 years of experience specializing in Biochemistry and Molecular Biology at Clinical Laboratories Science, Applied Medical College, JU university. Interested in genetics fields and Molecular techniques related to clinical studies

Experienced at Biochemistry and Molecular Biology and intellectually curious person always seeking new information and driving research forward. Balances classroom, laboratory and practice time to create knowledgeable, confident students. Multi-published researcher with history of running successful studies with students.

Expert in molecular biology techniques with background in classroom education and student mentoring. Dedicated to elevating student knowledge and abilities through challenging coursework and in-depth lectures. Runs organised, well-targeted courses to meet students' learning needs.

Respected academic with history of facilitating deep learning in large groups in person and online. Adapts to students' needs to deliver top quality lectures and seminars. Leads and supervises in-depth research projects on clinical chemistry, molecular techniques, and genetics studies.

Consultant of Clinical Biochemistry

1. Selim, S.; Akhtar, N.; El Azab, E.; Warrad, M.; Alhassan, H.H.; Abdel Mawgoud, M.; Al Jaouni, S.K.; Abdelgawad, H. Innovating the Synergistic Assets of β-amino Butyric Acid (BABA) and Selenium Nanoparticles (SeNPs) in Improving the Growth, Nitrogen Metabolism, Biological Activities, and Nutritive Value of Medicago interexta Sprouts. Plants-Basel, 2022, 11(3), 306.

2. Alzarea, S.I.; Alhassan, H.H.; Alzarea, A.I.; Al-Oanzi, Z.H.; Afzal, M. Antidepressant-like Effects of Renin Inhibitor Aliskiren in an Inflammatory Mouse Model of Depression. Brain Sci. 2022, 12, 655.

3.  Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan, H.H, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. J Biomol Struct Dyn. 2023 Sep-Oct;41(15):7511-7533. doi: 10.1080/07391102.2022.2120541. Epub 2022 Sep 12. PMID: 36093963. 

4. Elderdery AY, Tebein EM, Alenazy FO, Elkhalifa AME, Shalabi MG, Abbas AM, Alhassan HH, Davuljigari CB, Mills J. Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients. Genes (Basel). 2022 Sep 26;13(10):1729. doi: 10.3390/genes13101729. PMID: 36292614; PMCID: PMC9602384. 

5. Adnan M, Anwar S, DasGupta D, Patel M, Elasbali AM, Alhassan HH, Shafie A, Siddiqui AJ, Bardakci F, Snoussi M, Hassan MI. Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease. Int J Biol Macromol. 2023 Jan 1;224:188-195. doi: 10.1016/j.ijbiomac.2022.10.115. Epub 2022 Oct 17. PMID: 36257368. 

6. Adnan M, Shamsi A, Elasbali AM, Siddiqui AJ, Patel M, Alshammari N, Alharethi SH, Alhassan HH, Bardakci F, Hassan MI. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy. Int J Mol Sci. 2022 Oct 29;23(21):13172. doi: 10.3390/ijms232113172. PMID: 36361954; PMCID: PMC9655700. 

7. Al-Oanzi ZH, Alenazy FO, Alhassan HH, El-Aassar MR, Alzarea AI, Alzarea SI, Abbas AM, Alanazi MH, Al-Enazi MM. Effects of Thymoquinone Alone or in Combination with Losartan on the Cardiotoxicity Caused by Oxidative Stress and Inflammation in Hypercholesterolemia. J Cardiovasc Dev Dis. 2022 Dec 1;9(12):428. doi: 10.3390/jcdd9120428. PMID: 36547425; PMCID: PMC9782872. 

8. Alzarea, S.I.; Qasim, S.; Afzal, M.; Alsaidan, O.A.; Alhassan, H.H.; Alharbi, M.; Alqinyah, M.; Alenazi, F.S. Anandamide Reuptake Inhibitor (VDM11) as a Possible Candidate for COVID-19 Associated Depression; a Combination of Network Pharmacology, Molecular Docking and In Vivo Experimental Analysis. Processes 2023, 11, 143. https://doi.org/10.3390/pr11010143 

9. Elasbali AM, Al-Soud WA, Alhassan HH, Mousa Elayyan AE, Kamal M, Alanazi H, Alharbi B, Alharethi SH, Mohamed BM. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies. J Biomol Struct Dyn. 2023 Jan 16:1-9. doi: 10.1080/07391102.2023.2167864. Epub ahead of print. PMID: 36644886. 

10. Elfaki EM, Alhassan HH, Kamal M, Al-Enazi MM, Rub MA, Asiri AM, Ali M, Marwani HM, Alharethi SH, Alotaibi MM, Azum N. Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach. J Biomol Struct Dyn. 2023 Feb 8:1-10. doi: 10.1080/07391102.2023.2176362. Epub ahead of print. PMID: 36752377. 

11. Elasbali AM, Al-Soud WA, Mousa Elayyan AE, Al-Oanzi ZH, Alhassan HH, Mohamed BM, Alanazi HH, Ashraf MS, Moiz S, Patel M, Patel M, Adnan M. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer. J Biomol Struct Dyn. 2023 Mar 21:1-17. doi: 10.1080/07391102.2023.2191719. Epub ahead of print. PMID: 36943780. 

12. Alharethi SH, Kamal T, Alharbi B, Alhassan HH, Hakami MA, Alotaibi BS, Rub MA, Marwani HM, Alamry KA, Asiri AM, Azum N. Signal Transducer and Activator of Transcription 6 Changes and Protein Frustration by Single Amino Acid Substitutions: Implications for Cancer Progression. OMICS. 2023 Apr;27(4):171-179. doi: 10.1089/omi.2023.0020. PMID: 37043379. 

13. Al-Oanzi ZH, Alenazy FO, Alhassan HH, Alruwaili Y, Alessa AI, Alfarm NB, Alanazi MO, Alghofaili SI. The Role of Vitamin D in Reducing the Risk of Metabolic Disturbances That Cause Cardiovascular Diseases. J Cardiovasc Dev Dis. 2023 May 11;10(5):209. doi: 10.3390/jcdd10050209. PMID: 37233176; PMCID: PMC10219128. 

14. Asif Ali M, Khan N, Kaleem N, Ahmad W, Alharethi SH, Alharbi B, Alhassan HH, Al-Enazi MM, Razis AFA, Modu B, Calina D, Sharifi-Rad J. Anticancer properties of sulforaphane: current insights at the molecular level. Front Oncol. 2023 Jun 16;13:1168321. doi: 10.3389/fonc.2023.1168321. PMID: 37397365; PMCID: PMC10313060. 

15. Alhassan HH, Al-Keridis LA, Ayub H, Alenazy FO, Alruwaili Y, Khan MR, Fatima M, Patel M, Alshammari N, Adnan M, Sahreen S. GC-MS-based profiling and ameliorative potential of Carissa opaca Stapf ex Haines fruit against cardiac and testicular toxicity: An In vivo study. Heliyon. 2023 Aug 19;9(8):e19324. doi: 10.1016/j.heliyon.2023.e19324. PMID: 37664756; PMCID: PMC10469965. 

16. Mathur Y, Shafie A, Alharbi B, Ashour AA, Al-Soud WA, Alhassan HH, Alharethi SH, Anjum F. Genome-Wide Analysis of Kidney Renal Cell Carcinoma: Exploring Differentially Expressed Genes for Diagnostic and Therapeutic Targets. OMICS. 2023 Aug;27(8):393-401. doi: 10.1089/omi.2023.0056. PMID: 37624678. 

17. El Azab, E.F.; Alakilli, S.Y.M.; Saleh, A.M.; Alhassan, H.H.; Alanazi, H.H.; Ghanem, H.B.; Yousif, S.O.; Alrub, H.A.; Anber, N.; Elfaki, E.M.; et al. Actinidia deliciosa Extract as a Promising Supplemental Agent for Hepatic and Renal Complication-Associated Type 2 Diabetes (In Vivo and In Silico-Based Studies). Int. J. Mol. Sci. 2023, 24, 13759. https://doi.org/10.3390/ijms241813759 

18. Alhassan HH, Alruwaili YS, Alzarea SI, Alruwaili M, Alsaidan OA, Alzarea AI, Manni E, Tahir Ul Qamar M. Identification and dynamics of novel scaffolds against Enterococcus faecium serine hydroxymethyltransferase enzyme: a potential target for antibiotics development. J Biomol Struct Dyn. 2023 Sep 15:1-11. doi: 10.1080/07391102.2023.2257313. Epub ahead of print. PMID: 37713363.

19. Elasbali, A. M., Al-Soud, W. A., Mousa Elayyan, A. E., Alhassan, H. H., Danciu, C., Elfaki, E. M., Adnan, M. (2023). Antioxidative and ROS-dependent apoptotic effects of Cuscuta reflexa Roxb. stem against human lung cancer: network pharmacology and in vitro experimental validation. Journal of Biomolecular Structure and Dynamics, 1–26. https://doi.org/10.1080/07391102.2023.2263889.

20. Wu D, Li X, Wan H, Shami A, Alhassan HH, Al-Enazi MM, Mir Najib Ullah SN, Nashwan AJ, Khan S. Analysis of prevalence of adverse events connected with anti-tuberculosis drugs during pregnancy: A meta-analysis. Heliyon. 2023 Nov 23;9(12):e22786. doi: 10.1016/j.heliyon.2023.e22786. PMID: 38046152; PMCID: PMC10687699.

21. Alharbi B, Alnajjar LI, Alhassan HH, Khan S, Jawaid T, Abdullaev BS, Alshammari N, Yadav DK, Adnan M, Shamsi A. Identification of mitogen-activated protein kinase 7 inhibitors from natural products: Combined virtual screening and dynamic simulation studies. J Mol Recognit. 2024 Jan;37(1):e3067. doi: 10.1002/jmr.3067. Epub 2023 Nov 13. PMID: 37956676.

22. Alsaidan AA, Thirunavukkarasu A, Alhassan HH, Bin Ahmed IA, Alnasiri AS, Alhirsan WM, Alazmi NNM, Alkhlaf AK, Alderbas JM, Alkhaldi MA. Evaluation of Self-Management Behaviors and Its Correlation with the Metabolic Syndrome among the Type 2 Diabetes Mellitus Patients of Northern Saudi Arabia. J Clin Med. 2023 Dec 25;13(1):118. doi: 10.3390/jcm13010118. PMID: 38202125; PMCID: PMC10779580.

23. Elasbali, A. M., Al-Soud, W. A., Adnan, M., Alhassan, H. H., Mohammad, T., & Hassan, M. I. (2024). Discovering Promising Biomarkers and Therapeutic Targets for Duchenne Muscular Dystrophy: A Multiomics Meta-Analysis Approach. Molecular Neurobiology, 1-12.

24. Elasbali AM, Al-Soud WA, Anwar S, Alhassan HH, Adnan M, Hassan MI. A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy. Int J Biol Macromol. 2024 Apr;264(Pt 1):130544. doi: 10.1016/j.ijbiomac.2024.130544. Epub 2024 Feb 29. PMID: 38428778.

25. Alhassan HH. Network Pharmacology, Molecular Docking and Dynamics Analysis of Honokiol Against Triple-Negative Breast Cancer. HJHS, Accepted paper. 

26. Elasbali AM, Al-Soud WA, Anwar S, Alhassan HH, Adnan M, Hassan MI. A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy. Int J Biol Macromol. 2024 Apr;264(Pt 1):130544. doi: 10.1016/j.ijbiomac.2024.130544. Epub 2024 Feb 29. PMID: 38428778.

27. Alzarea AI, Saifullah A, Khan YH, Alanazi AS, Alatawi AD, Algarni MA, Almalki ZS, Alahmari AK, Alhassan HH, Mallhi TH. Evaluation of time to sputum smear conversion and its association with treatment outcomes among drug-resistant tuberculosis patients: a retrospective record-reviewing study. Front Pharmacol. 2024 Jun 5;15:1370344. doi: 10.3389/fphar.2024.1370344. PMID: 38898922; PMCID: PMC11186297.

28. Alhassan HH. Advanced vaccinomic, immunoinformatic, and molecular modeling strategies for designing Multi- epitope vaccines against the Enterobacter cloacae complex. Front Immunol. 2024 Aug 16;15:1454394. doi: 10.3389/fimmu.2024.1454394. PMID: 39221241; PMCID: PMC11362624.

29. Alsaidan OA, Ahmad N, Ejaz H, Hussain MA, Zafar A, Alhassan HH. Preparation and characterization of a ciprofloxacin-loaded nanoparticles incorporated polymeric film dressing. RSC Adv. 2024 Aug 29;14(38):27520-27529. doi: 10.1039/d4ra02951h. PMID: 39221130; PMCID: PMC11361098.

30. Alhassan HH, Ullah MI, Niazy AA, Alzarea SI, Alsaidan OA, Alzarea AI, Alsaidan AA, Alhassan AA, Alruwaili M, Alruwaili YS. Exploring glutathione transferase and Cathepsin L-like proteinase for designing of epitopes-based vaccine against Fasciola hepatica by immunoinformatics and biophysics studies. Front Immunol. 2024 Sep 26;15:1478107. doi: 10.3389/fimmu.2024.1478107. PMID: 39391319; PMCID: PMC11464328.

31. Nabil K. Alruwaili, Omar Awad Alsaidan, Ameeduzzafar Zafar, Alhassan HH, Eyad Abdulrazaq Alburaykan, Aseel Awad Alsaidan, Mohd Yasir, Lubhan Singh, Mohammad Khalid,
Rizatriptan loaded bilosomes for nose to brain delivery: Fabrication, statistical optimization, and biological evaluation,Journal of Drug Delivery Science and Technology,Volume 104,2025,106489,ISSN 1773-2247,https://doi.org/10.1016/j.jddst.2024.106489.

32. Alzarea SI, Afzal M, Moglad E, Alhassan HH, Alzarea AI, Alsaidan OA, Sayyed N, Kazmi I. In silico and in vivo evaluation of erucic acid against pentylenetetrazole-induced seizures in mice by modulating oxidative stress, neurotransmitters and neuroinflammation markers. Nutr Neurosci. 2025 Sep;28(9):1104-1119. doi: 10.1080/1028415X.2025.2463677. Epub 2025 Feb 28. PMID: 40022513.

33. Alruwaili M, Alhassan HH, Almutary H, Tahir Ul Qamar M. Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. Sci Rep. 2025 Apr 28;15(1):14824. doi: 10.1038/s41598-025-98516-9. Erratum in: Sci Rep. 2025 Sep 3;15(1):32354. doi: 10.1038/s41598-025-17853-x. PMID: 40295646; PMCID: PMC12037717.

34. Alzarea AI, Zafar A, Alsaidan OA, Alanazi AS, Alzarea SI, Alhassan HH, Uttekar PS. Preventive effect of acemannan on DMBA-induced mouse skin tumorigenesis by modulating inflammatory cytokines and apoptosis pathways: molecular docking and molecular dynamic simulation approaches. Int J Biol Macromol. 2025 Jun;311(Pt 4):143836. doi: 10.1016/j.ijbiomac.2025.143836. Epub 2025 May 1. PMID: 40318716.

35. Alzarea AI, Zafar A, Alsaidan OA, Alanazi AS, Alzarea SI, Alhassan HH, Uttekar PS. Preventive effect of acemannan on DMBA-induced mouse skin tumorigenesis by modulating inflammatory cytokines and apoptosis pathways: molecular docking and molecular dynamic simulation approaches. Int J Biol Macromol. 2025 Jun;311(Pt 4):143836. doi: 10.1016/j.ijbiomac.2025.143836. Epub 2025 May 1. PMID: 40318716.

36. Alhassan HH, Surti M, Adnan M, Patel M. Elucidation of Artemisinin as a Potent GSK3β Inhibitor for Neurodegenerative Disorders via Machine Learning-Driven QSAR and Virtual Screening of Natural Compounds. Pharmaceuticals (Basel). 2025 May 31;18(6):826. doi: 10.3390/ph18060826. PMID: 40573222; PMCID: PMC12196423.

37. Alzarea AI, Alhassan HH, Alzarea SI, Alanazi AS, Alotaibi FO, Alsaidan OW, Bakkari MA. Designing a Precision Epitope-Based Vaccine Against Paragonimus westermani Using Immunoinformatics, Biophysical Analysis, and Molecular Modeling Approaches. JOUR. 2025 JUNE 13. doi:10.1142/S2737416525500887.

38. Alsaidan AA, Alshehri AA, Thirunavukkarasu A, Alsaidan OA, Alhassan HH, Morad MH, Alshehari A, Alibrahim A. Exploring Health-Related Quality of Life and Correlates Among Patients with Type 2 Diabetes Mellitus Attending Primary Health Centers in Aljouf Province, Saudi Arabia: A Multi-Site Cross-Sectional Study. Risk Manag Healthc Policy. 2025 Jun 18;18:2007-2020. doi: 10.2147/RMHP.S514414. PMID: 40546452; PMCID: PMC12182739.

 39. Alhassan HH. Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy. Sci Rep. 2025 Jul 1;15(1):21632. doi: 10.1038/s41598-025-04129-7. PMID: 40593894; PMCID: PMC12217229.

40. Almarshad HA, Elderdery A, Madhavan M, Hoshino K, Alhassan HH, Manni E, Abbas AM, Alsuhami N, Alenazy FO, Almasoudi A, Sewelam A. Ultrastructural Features of Gold Nanoparticle Interactions with T47D Spheroids. Annu Int Conf IEEE Eng Med Biol Soc. 2025 Jul;2025:1-4. doi: 10.1109/EMBC58623.2025.11253115. PMID: 41337450.

41. Alruwaili M, Alhassan HH, Almutary H, Tahir Ul Qamar M. Correction: Computational identification of aspartic protease inhibitors for antimalarial drug development against Plasmodium Vivax. Sci Rep. 2025 Sep 3;15(1):32354. doi: 10.1038/s41598-025-17853-x. Erratum for: Sci Rep. 2025 Apr 28;15(1):14824. doi: 10.1038/s41598-025-98516-9. PMID: 40903486; PMCID: PMC12408814.

42. Alhassan HH, Surti M, Patel M. Computational prioritization of deleterious human myelin protein zero gene mutations reveals structural disruption and potential myelin dysfunction through dynamic simulations and stability analysis. J Biomol Struct Dyn. 2025 Oct 3:1-20. doi: 10.1080/07391102.2025.2564378. 

Epub ahead of print. PMID: 41039863.

43. Alzarea AI, Ishaqui AA, Maqsood MB, Alanazi AS, Alsaidan AA, Mallhi TH, Kumar N, Imran M, Alshahrani SM, Alhassan HH, Alzarea SI, Alsaidan OA. Evaluating AI performance in infectious disease education: a comparative analysis of ChatGPT, Google Bard, Perplexity AI, Microsoft Copilot, and Meta AI. Front Med (Lausanne). 2025 Oct 13;12:1679153. doi: 10.3389/fmed.2025.1679153. PMID: 41158456; PMCID: PMC12557576.

44. Alhassan HH, Janiyani K, Surti M, Adnan M, Patel M. The dual role of glycogen synthase kinase-3 beta (GSK3β) in neurodegenerative pathologies: interplay between autophagy and disease progression. Front Pharmacol. 2025 Oct 20;16:1693805. doi: 10.3389/fphar.2025.1693805. PMID: 41190025; PMCID: PMC12580362.

45. Alzarea AI, Ishaqui AA, Maqsood MB, Alanazi AS, Alsaidan AA, Mallhi TH, Kumar N, Orayj KM, Alshahrani SM, Alhassan HH, Alzarea SI, Alsaidan OA. Drug-induced headache reports: a comprehensive disproportionality and time-to-onset pharmacovigilance study using the FAERS database (2018-2024). Front Pain Res (Lausanne). 2025 Nov 7;6:1670648. doi: 10.3389/fpain.2025.1670648. PMID: 41282415; PMCID: PMC12634607.

46. Ibrahim Alzarea A, Athar Ishaqui A, Zeeshan M, Salah Alanazi A, Awad Alsaidan A, Hussain Mallhi T, Salman M, Habib Khan Y, Farooq J, Alhassan HH, I Alzarea S, Awad Alsaidan O. A systematic comparison of patient information leaflets from local and multinational pharmaceutical companies: Assessing content quality and completeness. PLoS One. 2025 Nov 7;20(11):e0335149. doi: 10.1371/journal.pone.0335149. PMID: 41202075; PMCID: PMC12594320.

47. Alzarea SI, Alsaidan OA, Qasim S, Alhassan HH, Alzarea AI, Alsahli TG, Alharbi M, Almutairi M. A network pharmacology and in silico approach to target NEU1-mediated microglial activation in neuroinflammation: Validation in an LPS-induced mouse model. Comput Biol Med. 2025 Dec;199:111318. doi: 10.1016/j.compbiomed.2025.111318. Epub 2025 Nov 18. PMID: 41260074.

48. Mohamed FAM, Alakilli SYM, Alhassan HH, Yousif SO, Alatwi E, Gomaa HAM, Alrub HA, Alyami BA, Abdelhafez AH, Bräse S, Youssif BGM. Design, synthesis, in silico studies, and antiproliferative activity of a novel series of thiazole/1,2,3-triazole hybrids as apoptosis inducers and multi-kinase inhibitors endowed with anti-breast cancer activity. RSC Adv. 2026 Jan 15;16(4):3349-3367. doi: 10.1039/d5ra07556d. PMID: 41550831; PMCID: PMC12805330.

49. Grant research by King Salman Center for Disability Research, grant number: KSRG-2024-392

50. Granted research by JU university and title is: Association of serum interleukin-6 (IL-6) levels and genetic association in patients with rheumatoid arthritis from Saudi Arabia.

51. Self Granted research: Computational and Network Pharmacological Evaluation of Potential Natural Product as Interleukin-6 Inhibitors to Combat Rheumatoid Arthritis. 

52. Granted research by JU university and title is: Evaluation of Anticancer Potential of Silver Nanoparticles Derived from Probiotic Bacteria against Leukemia. Grant number: DGSSR-2023-01-02357

53. Granted research by JU university and title is: Harnessing the power of Vitamin K: Exploring its Potential as an Anticancer Agent through Network Pharmacology and Experimental Validation. Grant number: DSR-2023-0X-02359

54. Granted by Jouf University. In-silico and In-vitro Investigation of Saponins Derived from Ajwa Dates Phoenix dactylifera L. (Arecaceae) against Metastatic Cancer. Grant number: DGSSR-2024-0X-01111

55. Granted by Jouf University. Discovery and Development of Human Biological Markers and Their Inhibitors from Saudi Arabian Medicinal Plants for Cancer Therapeutics. Grant number: DGSSR-2024-0X-02104

56. Granted by Jouf University. Phytosome-Based Nanoformulations for Targeted Therapy of Neurodegenerative Diseases: Enhancing Bioavailability and Neuroprotectionf. Grant number: DGSSR-2025-0X-01377

1. Clinical Laboratory Specialist for one year as internship, King Abdul-Aziz University Hospital and King Khaled University Hospital at King Saud University at city of Riyadh in Saudi Arabia

2. Teaching for courses at clinical laboratories science, applied medical college, JU university like as: Medical Genetic, Molecular Genetic, Diagnostic Molecular Biology, Clinical Practice Biochemistry, Diagnostic clinical chemistry, Biochemistry, and etc.

3. Members and supervisors for some committees at Clinical Laboratories Science Department, applied Medical College, JU university:

4. Supervisor for learning resource committee and members in some committees at Applied Medical College at JU University.

5. Member at permanent committee for operating medical clinics at JU university in 1444.

6. Supervisor of graduations research for clinical laboratory students.

7. Working in the field of volunteering.

Confocal Microscopy at central Lab at JU University 2020

Joined to couples conferences 2021-2023.

Assistant Professor at Clinical Laboratories Science Department, Applied Medical College, JU University. 2nd Floor, office number S091. Office Telephone number: +96614 654 4014

Website: https://www.ju.edu.sa